Ian Karp
Head of Investor Relations
Replay available
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.

Head of Investor Relations
President and Chief Executive Officer
Chief Commercial Officer
Chief Financial Officer
Analyst, Truist Securities
Analyst, Needham & Company
Analyst, Piper Sandler
Watch the replay and follow the connected company analysis, news, and investor updates for Collegium Pharmaceutical, Inc..
WEBVTT 00:00:00.031 -- 00:00:04.157 Greetings and welcome to the Collegium Pharmaceuticals second quarter 2025 earnings conference 00:00:04.157 -- 00:00:08.242 call. This time all participants are in listen only mode. 00:00:08.242 -- 00:00:12.408 The question and answer session will follow the formal presentation. 00:00:12.408 -- 00:00:15.833 If anyone should require operator assistance during the conference, please press star 00:00:15.833 -- 00:00:18.277 zero from your telephone keypad. 00:00:18.277 -- 00:00:21.578 Please note this conference is being recorded. 00:00:21.801 -- 00:00:27.009 I'll now turn the conference over to Ian Karp, head of investor relations at Collegium. 00:00:27.009 -- 00:00:30.170 Thank you. You may now begin your presentation. 00:00:31.115 -- 00:00:35.682 Great, thanks, and welcome to Collegium Pharmaceutical's second quarter 2025 earnings 00:00:35.682 -- 00:00:40.088 conference call. I'm joined today by Vikram Karnani, our President and Chief Executive 00:00:40.088 -- 00:00:45.035 Officer, Colleen Tupper, our Chief Financial Officer, and Scott Dreyer, our Chief Commercial 00:00:45.035 -- 00:00:49.501 Officer. Before we begin today's call, we want to remind participants that none of the 00:00:49.501 -- 00:00:53.888 information presented today is intended to be promotional and that any forward-looking 00:00:53.888 -- 00:00:58.013 statements made today are made pursuant to the safe harbor provisions of the Private 00:00:58.013 -- 00:01:01.135 Securities Litigation Reform Act of 1995. 00:01:01.135 -- 00:01:05.619 You are cautioned that such forward-looking statements involve risks and uncertainties 00:01:05.619 -- 00:01:09.302 as detailed in the company's periodic reports filed with the Securities and Exchange 00:01:09.302 -- 00:01:14.307 Commi...